Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Sangamo and Schering AG enter research agreement for Universal GeneTools technology

Aug. 26, 1999

Study commences of pulmonary delivery of migraine therapy

Aug. 23, 1999

Stem Cell Sciences and Rhone-Poulenc Rorer enter agreement

Aug. 23, 1999

ImmGenics' SLAM technology presented at conference

Aug. 20, 1999

Medi-Ject proceeds with development of needle-free device for male impotence therapy

Aug. 18, 1999

CAT and HGS enter agreement for therapeutic antibody development

Aug. 17, 1999

Argent gene delivery platform used successfully for sustained, controlled delivery of hGH

Aug. 16, 1999

Creative BioMolecules, NeoGenesis team up to identify new drugs to treat degenerative disorders

Aug. 16, 1999

Immune Complex Corporation awarded SBIR contract to detect cytochrome P450 polymorphisms

Aug. 16, 1999

Aastrom Biosciences enters distribution agreements for Norway and Switzerland

Aug. 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...